Toripalimab Plus TPF Chemotherapy and Radiotherapy for LA-HPSCC
Condition(s):Hypopharyngeal Neoplasm Malignant PrimaryLast Updated:November 10, 2020Not yet recruiting
Hide Studies Not Open or Pending
Condition(s):Hypopharyngeal Neoplasm Malignant PrimaryLast Updated:November 10, 2020Not yet recruiting
Condition(s):Laryngeal Neoplasms; Hypopharyngeal NeoplasmsLast Updated:March 1, 2019Completed
Condition(s):Hypopharyngeal Neoplasms; Laryngeal Neoplasms; Head and Neck CancersLast Updated:November 3, 2016Terminated
Condition(s):OSA; Oral Disease; Oropharyngeal Neoplasms; Hypopharyngeal NeoplasmsLast Updated:March 16, 2016Completed
Condition(s):Hypopharyngeal CancerLast Updated:February 20, 2024Recruiting
Condition(s):Hypopharyngeal Cancer; Immunotherapy; Induction ChemotherapyLast Updated:August 19, 2021Unknown status
Condition(s):Hypopharyngeal CancerLast Updated:December 9, 2019Completed
Condition(s):Larynx Cancer; Hypopharyngeal CancerLast Updated:September 15, 2023Recruiting
Condition(s):Head and Neck CancerLast Updated:December 20, 2023Completed
Condition(s):Laryngeal Cancer; Hypopharyngeal CancerLast Updated:June 15, 2022Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.